BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes

Trial Profile

BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Sep 2017

At a glance

  • Drugs Minocycline (Primary)
  • Indications Acne
  • Focus First in man; Therapeutic Use
  • Sponsors BioPharmX Corporation
  • Most Recent Events

    • 26 Jan 2017 According to a BioPharmX Corporation media release, data from this trial will be presented at SPIE Photonics West.
    • 22 Aug 2016 Results published in BioPharmX media release.
    • 22 Aug 2016 Primary endpoint (Logarithmic Change in Colony Counts of Facial Propionibacterium acnes at four weeks compared to baseline) has been met, as per BioPharmX media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top